Contrast agents and cardiac MR imaging of myocardial ischemia: From bench to bedside

European Radiology

Volumn 16, Issue 9, 2006, Pages 1951-1963

  Croisille, Pierre ^a   Revel, Didier ^a   Saeed, Maythem ^b  

^a LOUIS PRADEL HOSPITAL   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast media; Magnetic resonance imaging; Myocardial infarction; Myocardial ischemia; Myocardial viability

Indexed keywords

ADENOSINE; CONTRAST MEDIUM; DEXTRAN; DIPYRIDAMOLE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOMELITOL; GADOMER 17; NC 1001150; POLYLYSINE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

CLINICAL EFFECTIVENESS; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; FIRST PASS EFFECT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POINT OF CARE TESTING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPERFUSION INJURY; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STATISTICAL SIGNIFICANCE;

EID: 33746910544     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0244-z     Document Type: Review

References (99)

1. Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent. Am J Roentgenol 142:619-624
2. Fritz-Hansen T, Rostrup E, Sondergaard L et al (1998) Capillary transfer constant of Gd-DTPA in the myocardium at rest and during vasodilation assessed by MRI. Magn Reson Med 40:922-929
3. Arheden H, Saeed M, Higgins CB et al (2000) Reperfused rat myocardium subjected to various durations of ischemia: Estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 215:520-528
4. Saeed M, Higgins CB, Geschwind JF, Wendland MF (2000) T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging. Eur Radiol 10:310-318
5. Wendland MF, Saeed M, Lauerma K et al (1997) Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn Reson Med 37:448-456
6. Flacke SJ, Fischer SE, Lorenz CH (2001) Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: Normal distribution and elevation in acute and chronic infarction. Radiology 218:703-710
7. Port M, Corot C, Rousseaux O et al (2001) P792: A rapid clearance blood pool agent for magnetic resonance imaging: Preliminary results. Magma 12:121-127
8. Roberts HC, Saeed M, Roberts TP, Muhler A, Brasch RC (1999) MRI of acute myocardial ischemia: Comparing a new contrast agent, Gd-DTPA-24-cascade-polymer, with Gd-DTPA. J Magn Reson Imaging 9:204-208
9. Jerosch-Herold M, Wilke N, Wang Y et al (1999) Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group. Int J Card Imaging 15:453-464
10. Krombach GA, Higgins CB, Chujo M, Saeed M (2002) Blood pool contrast-enhanced MRI detects suppression of microvascular permeability in early postinfarction reperfusion after nicorandil therapy. Magn Reson Med 47:896-902
11. Krombach GA, Wendland MF, Higgins CB, Saeed M (2002) MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: Value of blood pool ultrasmall superparamagnetic particles of iron oxide. Radiology 225:479-486
12. Dewey M, Kaufels N, Laule M et al (2004) Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium. Magn Reson Med 51:703-709
13. Dewey M, Kaufels N, Laule M et al (2004) Magnetic resonance imaging of myocardial perfusion and viability using a blood pool contrast agent. Invest Radiol 39:498-505
14. Marchal G, Ni Y, Herijgers P et al (1996) Paramagnetic metalloporphyrins: Infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 6:2-8
15. Pislaru SV, Ni Y, Pislaru C et al (1999) Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 99:690-696
16. Saeed M, Bremerich J, Wendland MF et al (1999) Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 213:247-257
17. Saeed M, Lund G, Wendland MF et al (2001) Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 103:871-876
18. Weissleder R, Lee AS, Khaw BA, Shen T, Brady TJ (1992) Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 182:381-385
19. Perez JM, Josephson L, Weissleder R (2004) Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chembiochem 5:261-264
20. Bache RJ, Schwartz JS (1982) Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow. Circulation 65:928-935
21. Klocke FJ, Simonetti OP, Judd RM et al (2001) Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation 104:2412-2416
22. Lee DC, Simonetti OP, Harris KR et al (2004) Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation 110:58-65
23. Al-Saadi N, Nagel E, Gross M et al (2000) Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101:1379-1383
24. Schwitter J, Nanz D, Kneifel S et al (2001) Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: A comparison with positron emission tomography and coronary angiography. Circulation 103:2230-2235
25. Nagel E, Klein C, Paetsch I et al (2003) Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108:432-437
26. Paetsch I, Jahnke C, Wahl A et al (2004) Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 110:835-842
27. Slavin GS, Wolff SD, Gupta SN, Foo TK (2001) First-pass myocardial perfusion MR imaging with interleaved notched saturation: Feasibility study. Radiology 219:258-263
28. Wilke N, Jerosch-Herold M, Wang Y et al (1997) Myocardial perfusion reserve: Assessment with multisection, quantitative, first-pass MR imaging. Radiology 204:373-384
29. Epstein FH, London JF, Peters DC et al (2002) Multislice first-pass cardiac perfusion MRI: Validation in a model of myocardial infarction. Magn Reson Med 47:482-491
30. Schreiber WG, Schmitt M, Kalden P et al (2002) Dynamic contrast-enhanced myocardial perfusion imaging using saturation-prepared TrueFISP. J Magn Reson Imaging 16:641-652
31. Lauerma K, Virtanen KS, Sipila LM, Hekali P, Aronen HJ (1997) Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 96:2859-2867
32. Fenchel M, Helber U, Simonetti OP et al (2004) Multislice first-pass myocardial perfusion imaging: Comparison of saturation recovery (SR)-TrueFISP-two-dimensional (2D) and SR-TurboFLASH-2D pulse sequences. J Magn Reson Imaging 19:555-563
33. Di Bella EV, Parker DL, Sinusas AJ (2005) On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med 54:1295-1299
34. Markl M, Alley MT, Elkins CJ, Pelc NJ (2003) Flow effects in balanced steady state free precession imaging. Magn Reson Med 50:892-903
35. Giang TH, Nanz D, Coulden R et al (2004) Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: First European multi-centre experience. Eur Heart J 25:1657-1665
36. Arai AE (2000) Magnetic resonance first-pass myocardial perfusion imaging. Top Magn Reson Imaging 11:383-398
37. Haase A (1990) Snapshot FLASH MRI. Applications to T1, T2, and chemical-shift imaging. Magn Reson Med 13:77-89
38. Wedeking P, Sotak CH, Telser J et al (1992) Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. Magn Reson Imaging 10:97-108
39. Wilke N, Kroll K, Merkle H et al (1995) Regional myocardial blood volume and flow: First-pass MR imaging with polylysine-Gd-DTPA. J Magn Reson Imaging 5:227-237
40. Saeed M, Wendland MF, Yu KK et al (1994) Identification of myocardial reperfusion with echo planar magnetic resonance imaging. Discrimination between occlusive and reperfused infarctions. Circulation 90:1492-1501
41. Maki JH, Chenevert TL, Prince MR (1998) Contrast-enhanced MR angiography. Abdom Imaging 23:469-484
42. Canet E, Douek P, Janier M et al (1995) Influence of bolus volume and dose of gadolinium chelate for first-pass myocardial perfusion MR imaging studies. J Magn Reson Imaging 5:411-415
43. Wilke N, Simm C, Zhang J et al (1993) Contrast-enhanced first pass myocardial perfusion imaging: Correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 29:485-497
44. Christian TF, Rettmann DW, Aletras AH et al (2004) Absolute myocardial perfusion in canines measured by using dual-bolus first-pass MR imaging. Radiology 232:677-684
45. Kostler H, Ritter C, Lipp M et al (2004) Prebolus quantitative MR heart perfusion imaging. Magn Reson Med 52:296-299
46. Neyran B, Janier MF, Casali C, Revel D, Canet Soulas EP (2002) Mapping myocardial perfusion with an intravascular MR contrast agent: Robustness of deconvolution methods at various blood flows. Magn Reson Med 48:166-179
47. Carme S, Maï W, Mazzadi A et al (2006) Importance of parametric mapping and deconvolution in analyzing MR myocardial perfusion images. Invest Radiol 41(4):374-383
48. Bremerich J, Buser P, Bongartz G et al (1997) Noninvasive stress testing of myocardial ischemia: Comparison of GRE-MRI perfusion and wall motion analysis to 99 mTc-MIBI-SPECT, relation to coronary angiography. Eur Radiol 7:990-995
49. Saeed M, Wendland MF, Lauerma K et al (1995) First-pass contrast-enhanced inversion recovery and driven equilibrium fast GRE imaging studies: Detection of acute myocardial ischemia. J Magn Reson Imaging 5:515-523
50. Saeed M, Wendland MF, Szolar D et al (1996) Quantification of the extent of area at risk with fast contrast-enhanced magnetic resonance imaging in experimental coronary artery stenosis. Am Heart J 132:921-932
51. Sakuma H, Wendland MF, Saeed M et al (1995) Multislice measurement of first-pass transit of gadobenate dimeglumine in normal and ischemic myocardium in dogs. Acad Radiol 2:864-870
52. Schwitter J, Saeed M, Wendland MF et al (1999) Assessment of myocardial function and perfusion in a canine model of non-occlusive coronary artery stenosis using fast magnetic resonance imaging. J Magn Reson Imaging 9:101-110
53. Szolar DH, Saeed M, Wendland MF et al (1996) MR imaging characterization of postischemic myocardial dysfunction ("stunned myocardium"): relationship between functional and perfusion abnormalities. J Magn Reson Imaging 6:615-624
54. Wendland MF, Saeed M, Masui T, Derugin N, Higgins CB (1993) First pass of an MR susceptibility contrast agent through normal and ischemic heart: Gradient-recalled echo-planar imaging. J Magn Reson Imaging 3:755-760
55. Schwitter J, Saeed M, Wendland MF et al (1997) Influence of severity of myocardial injury on distribution of macromolecules: Extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 30:1086-1094
56. Yu KK, Saeed M, Wendland MF et al (1993) Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction. Invest Radiol 28:1015-1023
57. Been M, Smith MA, Ridgway JP et al (1988) Serial changes in the T1 magnetic relaxation parameter after myocardial infarction in man. Br Heart J 59:1-8
58. de Roos A, van Voorthuisen AE (1991) Magnetic resonance imaging of the heart: Perfusion, function, and structure. Curr Opin Radiol 3:525-532
59. Higgins CB (1994) Contribution of MR imaging in ischemic heart disease. J Magn Reson Imaging 4:233-234
60. Dulce MC, Duerinckx AJ, Hartiala J et al (1993) MR imaging of the myocardium using nonionic contrast medium: Signal-intensity changes in patients with subacute myocardial infarction. AJR Am J Roentgenol 160:963-970
61. Eichstaedt HW, Felix R, Dougherty FC et al (1986) Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA. Clin Cardiol 9:527-535
62. Van Dijkman PR, Van der Wall EE, De Roos A et al (1991) Acute, subacute, and chronic myocardial infarction: Quantitative analysis of gadolinium-enhanced MR images. Radiology 180:147-151
63. Cullen JH, Horsfield MA, Reek CR et al (1999) A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 33:1386-1394
64. Judd RM, Lugo-Olivieri CH, Arai M et al (1995) Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92:1902-1910
65. Rogers WJ Jr, Kramer CM, Geskin G et al (1999) Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 99:744-750
66. Lim TH, Choi SI (1999) MRI of myocardial infarction. J Magn Reson Imaging 10:686-693
67. Van Rossum AC, Visser FC, Van Eenige MJ et al (1990) Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol 65:845-851
68. Dendale P, Franken PR, Block P, Pratikakis Y, De Roos A (1998) Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 135:875-880
69. Saeed M, Wendland MF, Masui T, Higgins CB (1994) Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: Evidence for loss of compartmentalization of contrast media. Magn Reson Med 31:31-39
70. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM (2002) Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105:224-229
71. Pennell DJ, Sechtem UP, Higgins CB et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25:1940-1965
72. Selvanayagam JB, Porto I, Channon K et al (2005) Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury. Insights from cardiovascular magnetic resonance imaging. Circulation 111:1027-1032
73. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE (2004) Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 43:2253-2259
74. Haase J, Bayar R, Hackenbroch M et al (2004) Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol 17:367-373
75. Choi KM, Kim RJ, Gubernikoff G et al (2001) Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104:1101-1107
76. Arteaga C, Revel D, Zhao S et al (1999) Myocardial "low reflow" assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model. J Magn Reson Imaging 9:679-684
77. Bremerich J, Wendland MF, Arheden H et al (1998) Microvascular injury in reperfused infarcted myocardium: Noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging. J Am Coll Cardiol 32:787-793
78. Canet E, Revel D, Sebbag L et al (1995) Noninvasive assessment of no-reflow phenomenon in a canine model of reperfused infarction by contrast-enhanced magnetic resonance imaging. Am Heart J 130:949-956
79. Gerber BL, Rochitte CE, Melin JA et al (2000) Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 101:2734-2741
80. Kim RJ, Hillenbrand HB, Judd RM (2000) Evaluation of myocardial viability by MRI. Herz 25:417-430
81. Rochitte CE, Lima JA, Bluemke DA et al (1998) Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 98:1006-1014
82. Wu KC, Kim RJ, Bluemke DA et al (1998) Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 32:1756-1764
83. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA (2002) Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106:1083-1089
84. Taylor AJ, Al-Saadi N, Abdel-Aty H et al (2004) Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 109:2080-2085
85. Saeed M, Wendland MF, Watzinger N, Akbari H, Higgins CB (2000) MR contrast media for myocardial viability, microvascular integrity and perfusion. Eur J Radiol 34:179-195
86. Wendland MF, Saeed M, Lund G, Higgins CB (1999) Contrast-enhanced MRI for quantification of myocardial viability. J Magn Reson Imaging 10:694-702
87. Choi SI, Choi SH, Kim ST et al (2000) Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model. Radiology 215:863-868
88. Ni Y, Pislaru C, Bosmans H et al (2001) Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging. Eur Radiol 11:876-883
89. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA (2001) Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 104:2838-2842
90. Fieno DS, Kim RJ, Chen EL et al (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36:1985-1991
91. Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992-2002
92. Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445-1453
93. Moon JC, McKenna WJ, McCrohon JA et al (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561-1567
94. McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54-59
95. Bogaert J, Dymarkowski S (2005) Delayed contrast-enhanced MRI: Use in myocardial viability assessment and other cardiac pathology. Eur Radiol 15(Suppl 2):B52-B58
96. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM (2000) Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 102:1678-1683
97. Saeed M, Lee RJ, Weber O et al (2005) Scarred myocardium imposes additional burden on remote viable myocardium despite a reduction in the extent of area with late contrast MR enhancement. Eur Radiol 16:1-10
98. Selvanayagam JB, Kardos A, Francis JM et al (2004) Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 110:1535-1541
99. Kellman P, Arai AE, McVeigh ER, Aletras AH (2002) Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 47:372-383